Nerve growth factor attenuates hippocampal cholinergic deficits and operant learning impairment in rats with entorhinal cortex lesions

Behavioural Pharmacology

Volumn 14, Issue 3, 2003, Pages 179-190

  Shimode, Hiroko ^a   Ueki, A ^a   Morita, Y ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

Acetylcholine; Alzheimer's disease; Entorhinal cortex; Fixed interval schedule learning; Hippocampal CA3 field; Ibotenic acid; Nerve growth factor; Rat; Synaptophysin

Indexed keywords

ACETYLCHOLINE; ACETYLCHOLINESTERASE; NERVE GROWTH FACTOR; SYNAPTOPHYSIN;

ACETYLCHOLINE BRAIN LEVEL; ANIMAL BEHAVIOR; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; BRAIN REGION; CHOLINERGIC SYSTEM; CONTROLLED STUDY; DENSITOMETRY; DIALYSIS; DRUG EFFECT; ENTORHINAL CORTEX; HIPPOCAMPUS; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LEARNING DISORDER; MALE; NONHUMAN; RAT; STAINING; TASK PERFORMANCE;

EID: 0037672728     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008877-200305000-00001     Document Type: Article

References (51)

1. Altman J, Brunner RL, Bayer SA (1973). The hippocampus and behavioral maturation. Behav Biol 8:557-596.
2. Amaral DG, Kurz J (1985). An analysis of the origins of the cholinergic and noncholinergic septal projections to the hippocampal formation of the rat. J Comp Neurol 240:37-59.
3. Araujo DM, Chabot JG, Quirion R (1990). Potential neurotrophic factors in the mammalian central nervous system: functional significance in the developing and aging brain. Int Rev Neurobiol 32:141-174.
4. c-src in intact synaptic vesicle. Oncogene 5:1019-1024.
5. Blackstard TW (1956). Commissural connections of the hippocampal region in the rat, with special reference to their mode of termination. J Comp Neurol 105:417-537.
6. Braak H, Braak E (1991). Neuropathological staging of Alzheimer-related changes. Acta Neuropathol 82:239-259.
7. Day J, Damsma G, Fibiger HC (1991). Cholinergic activity in the rat hippocampus, cortex and striatum correlates with locomotor activity: an in vivo microdialysis study. Pharmacol Biochem Behav 38:723-729.
8. Dekker AJ, Fagan AM, Gage FH, Thal LJ (1994). Effects of brain-derived neurotrophic factor and nerve growth factor on remaining neurons in the lesioned nucleus basalis magnocellularis. Brain Res 639:149-155.
9. Douglas RJ (1967). The hippocampus and behavior. Psychol Bull 67:416-442.
10. Entingh D (1971). Perseverative responding and hyperphagia following entorhinal lesions in cats. J Comp Physiol Psychol 75:50-58.
11. Francis-Turner L, Valoušková V (1996.) Nerve growth factor and nootropic drug Cerebrolysin but not fibroblast growth factor can reduce spatial memory impairment elicited by fimbria-fornix transection: short-term study. Neurosci Lett 202:193-196.
12. Fraser KA, Poucet B, Partlow G, Herrmann T (1991). Role of medial and lateral septum in a variable goal spatial problem solving task. Physiol Behav 50:739-744.
13. Goto S, Hirano A (1990). Neuronal inputs to hippocampal formation in Alzheimer's disease and parkinsonism-dementia complex on Guam. Acta Neuropathol 79:545-550.
14. Guldin WO, Markowitsh HJ (1981). No detectable remote lesions following massive intrastriatal injections of ibotenic acid. Brain Res 225:446-451.
15. Hagg T, Manthorpe M, Vahlsing HL, Varon S (1988). Delayed treatment with nerve growth factor reverses the apparent loss of cholinergic neurons after acute brain damage. Exp Neurol 101:303-312.
16. Hefti F (1986). Nerve growth factor promotes survival of septal cholinergic neurons after fimbrial transections. J Neurosci 6:2155-2162.
17. Hefti F (1989). Nerve growth factor and neurotrophic factors in Parkinson's disease and aging. In: Parkinsonism and Aging. Calne DB, Comi G, Crippa D, Horowski R, Trabucchi M (eds). New York: Raven Press; pp. 79-88.
18. Hefti F, Hartikka J, Knusel B (1989). Function of neurotrophic factors in the adult and aging brain and their possible use in the treatment of neurodegenerative diseases. Neurobiol Aging 10:515-533.
19. Junard EO, Montero CN, Hefti F (1990). Long-term administration of mouse nerve growth factor to adult rats with partial lesions of the cholinergic septohippocampal pathway. Exp Neurol 110:25-38.
20. Knaus P, Betz H, Rehm H (1986). Expression of synaptophysin during postnatal development of the mouse brain. J Neurochem 47:1302-1304.
21. Köhler C, Schwarcz R, Fuxe K (1979). Intrahippocampal injections of ibotenic acid provide histological evidence for a neurotoxic mechanism different from kainic acid. Neurosci Lett 15:223-228.
22. 3H]acetylcholine release and choline acetyltransferase activity. Neuroscience 42:639-649.
23. Mark GP, Rada P, Pothos E, Hoebel BG (1992). Effects of feeding and drinking on acetylcholine release in the nucleus accumbens, striatum and hippocampus of freely behaving rats. J Neurochem 58:2269-2274.
24. Miwa C, Ueki A (1996). Effect of entorhinal cortex lesion on learning behavior and on hippocampus in the rat. Psychiatry Clin Neurosci 50:223-230.
25. Miwa C, Ueki A, Shinjo H, Shimode H, Morita Y (2001). Long-term synaptic alteration in the rat hippocampal CA3 field following an entorhinal cortex lesion. Psychiatry Clin Neurosci 55:573-578.
26. Montero CN, Hefti F (1988). Rescue of lesioned septal cholinergic neurons by nerve growth factor: specificity and requirement for chronic treatment. J Neurosci 8:2986-2999.
27. Myhrer T (1975). Locomotor and avoidance behavior in rats with partial or total hippocampal perforant paths sections. Physiol Behav 15:217-224.
28. Navone F, Jahn R, Di Gioia G, Stukenbrok H, Greengard P, De Camilli P (1986). Protein p38: an integral membrane protein specific for small vesicles of neurons and neuroendocrine cells. J Cell Biol 103:2511-2527.
29. Paxinos G, Watson C (1982.) The Rat Brain in Stereotaxic Coordinates. New York: Academic Press.
30. Perry EK, Perry RH, Blessed G, Tomlinson BE (1977). Necropsy evidence of central cholinergic deficits in senile dementia. Lancet 1:189.
31. Raisman G, Cowan WH, Powell TPP (1965). The extrinsic afferent, commissural, and association fibers of the hippocampus. Brain 88:963-996.
32. Ramirez JJ, Martin C, McQuilkin ML, MacDonald KA, Valbuena M, O'Connell JM (1995). Bilateral entorhinal cortex lesions impair DRL performance in rats. Psychobiology 23:37-44.
33. Rehm H, Wiedenmann B, Betz H (1986). Molecular characterization of synaptophysin, a major calcium-binding protein of the synaptic vesicle membrane. EMBO J 5:535-541.
34. Ruth RE, Collier TJ, Routtenberg A (1982). Topography between the entorhinal cortex and the dentate septotemporal axis in rats: I. Medial and intermediate entorhinal projecting cells. J Comp Neurol 209:69-78.
35. Schwartcz R, Hökfelt T, Fuxe K, Jonsson G, Goldstein M, Terenius L (1979). Ibotenic acid-induced neuronal degeneration: a morphological and neurochemical study. Exp Brain Res 37:199-216.
36. Segal M (1977). Afferents to the entorhinal cortex of the rat studied by the method of retrograde transport of horseradish peroxidase. Exp Neurol 57:750-765.
37. Shinjo H, Ueki A, Miwa C, Morita Y (1998). Effect of entorhinal cortex lesion on hippocampal cholinergic system in rat in operant learning task as studied by in vivo brain microdialysis. J Neurol Sci 157:13-18.
38. Stein DG, Will BE (1983). Nerve growth factor produces a temporary facilitation of recovery from entorhinal cortex lesions. Brain Res 261:127-131.
39. Steward O (1976). Topographic organization of the projections from the entorhinal area to the hippocampal formation of the rats. J Comp Neurol 167:285-314.
40. Sudhof TC, Lettspeich F, Greengard P, Mehl E, Jaln R (1987). A synaptic vesicle protein with a novel cytoplasmic domain and four transmembrane regions. Science 238:1142-1144.
41. Thoenen H, Bandtlow C, Heumann R (1987). The physiological function of nerve growth factor in the central nervous system: comparison with the periphery. Rev Physiol Biochem Pharmacol 109:145-178.
42. Thomas L, Hartung K, Langosch D, Pehm H, Bamberg E, Franke WW, Bert H (1988). Identification of synaptophysin as a hexameric channel protein of the synaptic vesicle membrane. Science 242:1050-1053.
43. Tuszynski MH (2000). Intraparenchymal NGF infusions rescue degenerating cholinergic neurons. Cell Transplant 9:629-636.
44. Ueki A, Miyoshi K (1989). Effects of cholinergic drugs on learning impairment in ventral globus pallidus-lesioned rats. J Neurol Sci 90:1-21.
45. Ueki A, Miwa C, Miyoshi K (1994). Impairment in the acquisition of passive and active avoidance learning tasks due to bilateral entorhinal cortex lesions. J Neurol Sci 125:14-21.
46. Ueki A, Miwa C, Oohara K, Miyoshi K (1996). Histological evidence for cholinergic alteration in the hippocampus following entorhinal cortex lesion. J Neurol Sci 142:7-11.
47. Van Hoesen GW (1982). The parahippocampal gyrus. New observations regarding its cortical connections in the monkey. Trends Neurosci 5:345-350.
48. Whittemore SR, Seiger A (1987). The expression, localization and functional significance of beta-nerve growth factor in the central nervous system. Brain Res 434:439-464.
49. Wiedenmann B, Franke WW (1985). Identification and localization of synaptophysin, an integral membrane glycoprotein of Mr 38,000 characteristic of presynaptic vesicles. Cell 41:1017-1028.
50. Will B, Hefti F (1985). Behavioural and neurochemical effects of chronic intraventricular injections of nerve growth factor in adult rats with fimbrial lesions. Behav Brain Res 17:17-24.
51. Winkler J, Power AE, Ramirez GA, Thal LJ (1998). Short-term and complete reversal of NGF effects in rats with lesions of the nucleus basalis magnocellularis. Brain Res 788:1-12.